A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation
NCT00143364
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1005
Enrollment
INDUSTRY
Sponsor class
Conditions
Smoking Cessation
Interventions
DRUG:
varenicline (CP-526,555)
Sponsor
Pfizer